Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional Results available

Dose-finding of Semaglutide Administered Subcutaneously Once Daily Versus Placebo and Liraglutide in Subjects With Type 2 Diabetes

ClinicalTrials.gov ID: NCT02461589

Public ClinicalTrials.gov record NCT02461589. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 28, 2026, 11:02 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This trial is conducted globally. The aim of this trial is to investigate dose-finding of semaglutide administered subcutaneously once daily versus placebo and liraglutide in subjects with type 2 diabetes

Study identification

NCT ID
NCT02461589
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Novo Nordisk A/S
Industry
Enrollment
706 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Sep 21, 2015 (Actual)
Primary completion
Oct 13, 2016 (Actual)
Completion
Oct 13, 2016 (Actual)
Last update posted
Jul 31, 2019

2015 – 2016

United States locations

U.S. sites
84
U.S. states
31
U.S. cities
74
Facility City State ZIP Site status
Novo Nordisk Investigational Site Birmingham Alabama 35209 —
Novo Nordisk Investigational Site Birmingham Alabama 35294 —
Novo Nordisk Investigational Site Coronado California 92118 —
Novo Nordisk Investigational Site Lancaster California 93534 —
Novo Nordisk Investigational Site Riverside California 92506 —
Novo Nordisk Investigational Site Tustin California 92780 —
Novo Nordisk Investigational Site Van Nuys California 91405 —
Novo Nordisk Investigational Site Vista California 92083 —
Novo Nordisk Investigational Site Walnut Creek California 94598 —
Novo Nordisk Investigational Site Hartford Connecticut 06105 —
Novo Nordisk Investigational Site Boca Raton Florida 33433 —
Novo Nordisk Investigational Site Gainesville Florida 32609 —
Novo Nordisk Investigational Site Gainesville Florida 32653 —
Novo Nordisk Investigational Site Hialeah Florida 33012 —
Novo Nordisk Investigational Site Miami Florida 33173 —
Novo Nordisk Investigational Site Miami Florida 33183 —
Novo Nordisk Investigational Site Pembroke Pines Florida 33026 —
Novo Nordisk Investigational Site Ponte Vedra Florida 32081 —
Novo Nordisk Investigational Site Atlanta Georgia 30342 —
Novo Nordisk Investigational Site Marietta Georgia 30067 —
Novo Nordisk Investigational Site Evanston Illinois 60201-2477 —
Novo Nordisk Investigational Site Evansville Indiana 47714 —
Novo Nordisk Investigational Site Newton Kansas 67114 —
Novo Nordisk Investigational Site Louisville Kentucky 40206 —
Novo Nordisk Investigational Site Madisonville Kentucky 42431 —
Novo Nordisk Investigational Site Marrero Louisiana 70072 —
Novo Nordisk Investigational Site Slidell Louisiana 70458 —
Novo Nordisk Investigational Site Slidell Louisiana 70461-4231 —
Novo Nordisk Investigational Site Rockville Maryland 20852 —
Novo Nordisk Investigational Site Boston Massachusetts 02215 —
Novo Nordisk Investigational Site Buckley Michigan 49620 —
Novo Nordisk Investigational Site Belzoni Mississippi 39038 —
Novo Nordisk Investigational Site Bridgeton Missouri 63044 —
Novo Nordisk Investigational Site Kalispell Montana 59901 —
Novo Nordisk Investigational Site Elkhorn Nebraska 68022 —
Novo Nordisk Investigational Site Las Vegas Nevada 89103 —
Novo Nordisk Investigational Site Lawrenceville New Jersey 08648 —
Novo Nordisk Investigational Site Hopewell Junction New York 12553 —
Novo Nordisk Investigational Site Statesville North Carolina 28625 —
Novo Nordisk Investigational Site Cincinnati Ohio 45219 —
Novo Nordisk Investigational Site Cincinnati Ohio 45227 —
Novo Nordisk Investigational Site Cincinnati Ohio 45255 —
Novo Nordisk Investigational Site Delaware Ohio 43015 —
Novo Nordisk Investigational Site Dublin Ohio 43016 —
Novo Nordisk Investigational Site Kettering Ohio 45429 —
Novo Nordisk Investigational Site Mason Ohio 45040-6815 —
Novo Nordisk Investigational Site Oklahoma City Oklahoma 73112 —
Novo Nordisk Investigational Site Corvallis Oregon 97330-3737 —
Novo Nordisk Investigational Site Downingtown Pennsylvania 19335-2620 —
Novo Nordisk Investigational Site Media Pennsylvania 19063 —
Novo Nordisk Investigational Site Smithfield Pennsylvania 15478 —
Novo Nordisk Investigational Site Uniontown Pennsylvania 15401 —
Novo Nordisk Investigational Site Charleston South Carolina 29412 —
Novo Nordisk Investigational Site Hodges South Carolina 29653 —
Novo Nordisk Investigational Site Mt. Pleasant South Carolina 29464 —
Novo Nordisk Investigational Site Old Point Station South Carolina 29707 —
Novo Nordisk Investigational Site Bristol Tennessee 37620-7352 —
Novo Nordisk Investigational Site Chattanooga Tennessee 37404 —
Novo Nordisk Investigational Site Johnson City Tennessee 37604 —
Novo Nordisk Investigational Site Kingsport Tennessee 37660 —
Novo Nordisk Investigational Site Memphis Tennessee 38119-4806 —
Novo Nordisk Investigational Site Nashville Tennessee 37203 —
Novo Nordisk Investigational Site Arlington Texas 76012-4637 —
Novo Nordisk Investigational Site Austin Texas 78705 —
Novo Nordisk Investigational Site Carrollton Texas 75010 —
Novo Nordisk Investigational Site Dallas Texas 75220 —
Novo Nordisk Investigational Site Dallas Texas 75230 —
Novo Nordisk Investigational Site Dallas Texas 75251 —
Novo Nordisk Investigational Site Dallas Texas 75390-9302 —
Novo Nordisk Investigational Site Houston Texas 77008 —
Novo Nordisk Investigational Site Missouri City Texas 77459 —
Novo Nordisk Investigational Site New Braunfels Texas 78130 —
Novo Nordisk Investigational Site San Antonio Texas 78230 —
Novo Nordisk Investigational Site San Antonio Texas 78258 —
Novo Nordisk Investigational Site Sugar Land Texas 77479 —
Novo Nordisk Investigational Site Waco Texas 76710 —
Novo Nordisk Investigational Site Bountiful Utah 84010 —
Novo Nordisk Investigational Site Clinton Utah 84015 —
Novo Nordisk Investigational Site Riverton Utah 84065 —
Novo Nordisk Investigational Site Richmond Virginia 23219 —
Novo Nordisk Investigational Site Virginia Beach Virginia 23454 —
Novo Nordisk Investigational Site Winchester Virginia 22601 —
Novo Nordisk Investigational Site Renton Washington 98057 —
Novo Nordisk Investigational Site Spokane Washington 99216-1557 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 66 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT02461589, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jul 31, 2019 · Synced Oct 28, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT02461589 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →